Asset Details
Do you wish to reserve the book?
miR‐322‐5p targets IGF‐1 and is suppressed in the heart of rats with pulmonary hypertension
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
miR‐322‐5p targets IGF‐1 and is suppressed in the heart of rats with pulmonary hypertension
Do you wish to request the book?
miR‐322‐5p targets IGF‐1 and is suppressed in the heart of rats with pulmonary hypertension
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
miR‐322‐5p targets IGF‐1 and is suppressed in the heart of rats with pulmonary hypertension
2018
Overview
Pulmonary arterial hypertension (PAH) is characterised by remodelling of the pulmonary vasculature leading to right ventricular hypertrophy. Here, we show that miR‐322‐5p (the rodent orthologue of miR‐424‐5p) expression is decreased in the right ventricle of monocrotaline‐treated rats, a model of PAH, whereas a putative target insulin‐like growth factor 1 (IGF‐1) is increased. IGF‐1 mRNA was enriched 16‐fold in RNA immunoprecipitated with Ago2, indicating binding to miR‐322‐5p. In cell transfection experiments, miR‐322‐5p suppressed the activity of a luciferase reporter containing a section of the IGF‐1 3′ untranslated region (UTR) as well as IGF‐1 mRNA and protein levels. Taken together, these data suggest that miR‐322 targets IGF‐1, a process downregulated in PAH‐related RV hypertrophy. miRNA regulate various cell processes, which often go awry in disease. Here, we look at miR‐322‐5p, a miRNA downregulated in the hypertrophying right ventricle of rats with drug‐induced pulmonary arterial hypertension (PAH). Concomitantly, IGF‐1 is upregulated in these enlarged right ventricles. We confirmed that miR‐322‐5p targets IGF‐1, raising the possibility that reduced miR‐322‐5p contributes to the development of hypertrophy in PAH. By Mariana Ruiz [Public domain], via Wikimedia Commons.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc,Wiley
Subject
